Arecor Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Apr '26 Apr 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Market Capitalization	25	30	28	56	73	111	Upgrade
Market Cap Growth	73.68%	9.52%	-50.35%	-23.94%	-34.00%	-	Upgrade
Enterprise Value	19	29	25	48	60	89	Upgrade
Last Close Price	0.66	0.81	0.73	1.82	2.40	4.00	Upgrade
PE Ratio	27.93	45.77	-	-	-	-	Upgrade
PS Ratio	14.54	17.73	5.49	12.22	30.58	96.15	Upgrade
PB Ratio	3.86	4.71	5.19	5.87	4.21	6.00	Upgrade
P/TBV Ratio	3.87	4.72	5.22	8.97	5.23	6.01	Upgrade
EV/Sales Ratio	11.02	16.73	5.04	10.46	24.94	77.27	Upgrade
Debt / Equity Ratio	0.02	0.02	0.04	0.04	0.02	0.01	Upgrade
Net Debt / Equity Ratio	-0.93	-0.93	-0.57	-0.67	-0.72	-0.97	Upgrade
Net Debt / EBITDA Ratio	1.57	1.57	0.43	0.72	1.23	3.07	Upgrade
Net Debt / FCF Ratio	2.45	2.45	0.33	1.07	1.13	3.28	Upgrade
Asset Turnover	0.20	0.20	0.42	0.25	0.11	0.09	Upgrade
Inventory Turnover	-	-	5.62	3.49	-	-	Upgrade
Quick Ratio	4.35	4.35	2.08	1.96	4.19	8.77	Upgrade
Current Ratio	4.78	4.78	2.53	2.17	4.69	9.05	Upgrade
Return on Equity (ROE)	15.79%	15.79%	-137.62%	-63.41%	-51.44%	-63.85%	Upgrade
Return on Assets (ROA)	-30.05%	-30.05%	-38.43%	-30.88%	-30.28%	-29.64%	Upgrade
Return on Invested Capital (ROIC)	-898.75%	-276.24%	-272.54%	-227.95%	-382.93%	-3568.36%	Upgrade
Return on Capital Employed (ROCE)	-62.30%	-62.30%	-135.50%	-89.70%	-57.30%	-32.00%	Upgrade
Earnings Yield	2.66%	2.19%	-36.88%	-15.30%	-12.60%	-5.54%	Upgrade
FCF Yield	-9.88%	-8.10%	-33.07%	-10.72%	-15.08%	-4.96%	Upgrade
Buyback Yield / Dilution	-17.94%	-17.94%	-9.20%	-5.83%	-25.63%	-41.77%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.